| Literature DB >> 31616221 |
Ibrahim Halil Yavuz1, Goknur Ozaydın Yavuz1, Irfan Bayram2, Serap Gunes Bilgili1.
Abstract
INTRODUCTION: Pemphigus refers to a group of rare autoimmune vesiculobullous diseases with high morbidity and mortality, mainly affecting the skin and the mucosae. AIM: To evaluate the incidence of pemphigus in the Eastern region of Turkey by analysing the clinical characteristics of the patients including the drugs used in the treatment and their side-effect profiles and dosing schedules, duration of treatment, length of hospital stay, and the characteristics of the lesions.Entities:
Keywords: foods; pemphigus; smoking
Year: 2019 PMID: 31616221 PMCID: PMC6791153 DOI: 10.5114/ada.2019.87449
Source DB: PubMed Journal: Postepy Dermatol Alergol ISSN: 1642-395X Impact factor: 1.837
Patient characteristics
| Parameter | % | ||
|---|---|---|---|
| Gender | Male | 62 | 47.69 |
| Female | 68 | 52.31 | |
| Affected site | Skin | 8 | 6.15 |
| Mouth | 23 | 17.69 | |
| Both | 99 | 76.15 | |
| Smoking | No | 57 | 43.85 |
| Yes | 73 | 56.15 | |
| Intake of food suspected of triggering pemphigus (onion, garlic or leek) | No | 13 | 10.00 |
| Yes | 117 | 90.00 | |
| Anxiety disorder or depression | No | 85 | 65.38 |
| Yes | 45 | 34.62 | |
Distribution of pemphigus subtypes according to mean age and genders
| Pemphigus subtype | % | Mean age [years] | Gender | |
|---|---|---|---|---|
| Vulgaris | 122 | 93.85 | 51.72 ±12.71 | 56 M/66 F |
| Foliaceus | 4 | 3.08 | 54.75 ±18.21 | 4 M |
| Erythematous | 1 | 0.77 | 77.00 | 1 F |
| IgA | 1 | 0.77 | 51.00 | 1 M |
| Paraneoplastic | 1 | 0.77 | 73.00 | 1 M |
| Vegetans | 1 | 0.77 | 56.00 | 1 F |
| Total | 130 | 100.00 | 52.20 ±1.96 | 62 M/68 F |
M – male, F – female.
Mean and median values for age, hospital stay, diagnostic delay, initial steroid dosage, duration of disease, and length of time to disease control
| Parameter | Mean or median | SD or min.–max. |
|---|---|---|
| Age [years] | 52.20 | ±12.96 |
| Hospital stay [days] | 3.00 | 0.00–30.00 |
| Diagnostic delay [months] | 4.00 | 1.00–75.00 |
| Initial steroid dosage [mg] | 80.00 | 60.00–100.00 |
| Duration of disease [years] | 7.00 | 1.00–12.00 |
| Time to disease control [days] | 20.00 | 15.00–33.00 |
Distribution of pemphigus subtypes according to mean duration of disease
| Pemphigus subtype | Duration of disease [years] | ||||
|---|---|---|---|---|---|
| Mean | SD | Median | Min. | Max. | |
| Vulgaris | 6.93 | 3.28 | 7.00 | 1.00 | 12.00 |
| Foliaceus | 6.50 | 1.73 | 6.50 | 5.00 | 8.00 |
| Erythematous | 5.00 | – | 5.00 | 5.00 | 5.00 |
| IgA | 5.00 | – | 5.00 | 5.00 | 5.00 |
| Paraneoplastic | 5.00 | – | 5.00 | 5.00 | 5.00 |
| Vegetans | 7.00 | – | 7.00 | 7.00 | 7.00 |
Kruskal-Wallis test; p = 0.949.
Distribution of pemphigus subtypes according to the drugs used in the treatment
| Pemphigus type | Drugs | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steroid | Steroid + AZA | Steroid + MMP | Steroid + AZA + MMP | Steroid + AZA + IVIg | Steroid + AZA + MMP + IVIg | Steroid + AZA + MMP + CsA | ||||||||
| % | % | % | % | % | % | % | ||||||||
| Vulgaris | 30 | 24.59 | 68 | 55.73 | 2 | 1.63 | 1 | 0.82 | 14 | 11.47 | 6 | 4.18 | 1 | 0.82 |
| Foliaceus | 4 | 100 | ||||||||||||
| Erythematous | 1 | 100 | ||||||||||||
| IgA | 1 | 100 | ||||||||||||
| Paraneoplastic | 1 | 100 | ||||||||||||
| Vegetans | 1 | 100 | ||||||||||||
AZA – azathioprine, MMP – mycophenolate mophetil, CsA – cyclosporine.
Side effects of the treatment detected in the patients
| Side effects | % | |
|---|---|---|
| Oral candidiasis | 101 | 77.70 |
| Cushingoid appearance | 89 | 68.46 |
| Weight gain | 71 | 54.61 |
| Striae | 45 | 34.61 |
| Bacterial infection | 41 | 31.53 |
| Excessive hair growth | 33 | 25.38 |
| Osteoporosis | 29 | 22.30 |
| Glaucoma/cataract | 13 | 10.00 |
| Avascular necrosis | 11 | 8.46 |